Clinical trial
A Randomized, Double-blind, Placebo-controlled Multicenter Clinical Study of Gulingji Capsule in the Treatment of Idiopathic Oligospermia, Asthenia, and Teratozoospermia.
NCT05320536 is registered in ClinicalTrials.gov with Jinling Hospital, China as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-blind, Placebo-controlled Multicenter Clinical Study of Gulingji Capsule in the Treatment of Idiopathic Oligospermia, Asthenia, and Teratozoospermia.
- Lead sponsor
- Jinling Hospital, China
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- December 6, 2021
- Completion date
- December 31, 2022
- Enrollment
- 240 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.